Grace Therapeutics, Inc. (ACST)
3.24
-0.07
(-2.11%)
USD |
NASDAQ |
Dec 15, 16:00
Grace Therapeutics EPS Diluted (Quarterly): -0.0589 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.938M |
| Total Expenses (Quarterly) | 0.938M |
| Earnings Yield | -18.05% |
| Normalized Earnings Yield | -21.27 |